Adhezion Biomedical, LLC

Adhezion Biomedical, LLC

Adhezion Biomedical, LLC

Adhezion Biomedical, LLC is a privately‐held medical device company focused on the development and commercialization of highly differentiated cyanoacrylate based surgical, wound management and infection prevention technologies. Founded in 2001, the company is based in Wyomissing, Pennsylvania. Our Professional Products group concentrates on the development and commercialization of cyanoacrylate products for use in wound closure and wound care within a broad range of surgical and medical disciplines. These products address the needs of acute and non-acute hospital markets, surgery centers and physician office-based markets and in a large number of specialties including the long-term care market and vascular access. We have a robust product pipeline under development and several products that are being commercialized in the US and overseas markets.

Company details

One Meridian Blvd., Suite 1B02 , Wyomissing , Pennsylvania 19610 USA
View in map

Find locations served, office locations

Business Type:
Manufacturer
Industry Type:
Medical Equipment
Market Focus:
Internationally (various countries)

The vision of the Adhezion team is to redefine the way cyanoacrylate based surgical adhesives and sealants are used in medicine. Our mission is to provide technologies that achieve optimal patient outcomes. Adhezion currently is developing and commercializing cyanoacrylate-based adhesives and sealants for use in professional and consumer healthcare settings. We specialize in products that provide solutions for four distinct healthcare segments; Surgical, Wound Management, Infection Prevention and Vascular Access.

Adhezion is focused on producing the highest quality professional medical and consumer health products in an effort to provide the best possible patient clinical results. We will strive to provide superior service and products to professionals, patients and consumers alike, while building an innovative medical device company.

Our Vision is to create an exciting and successful biomedical company that develops exciting new wound closure, wound care and surgical drape sealant products. We will endeavor to explore new materials, formulations and technologies to produce new medical products that provide superior modalities to heal and close wounds, treat disease and prevent infection.

Idea

Adhezion's founders collaborated in advancing the clinical performance characteristics of cyanoacrylate adhesives

Development

Efforts were focused in developing new technologies for improved performance

Commercialization

With numerous regulatory approvals, the company is strategically poised to engage in commercialization of it's proprietary technology

  • 2001

    Founders created Spartan Medial Products LLC

  • 2002

    Company establishes manufacturing and R&D facility in Hudson, NC.

  • 2003

    Company files for initial patents on proprietary technologies.

  • 2007

    Received approval for first 510K application & CE Mark.

  • 2008

    Sercured $5.25 million in series 'A' Financing

    SURGISEAL receives CE Mark approval

    SURGISEAL Received FDA Market Clearance 

    FLORASEAL receives CE Mark approval

  • 2009

    FLORASEAL receives FDA Market Clearance

    US & OUS Distribution established

  • 2010

    Secured $2.5 million in Series 'B' Financing

  • 2011

    Secured $2.5M in financing & 2 major distribution agreements

  • 2012

    Secured $1 million in Series 'A' Financing

  • 2013

    Brought on second largest U.S. hospital supplies distributor

    Increased revenue by 75% over 2012 and increased net income threefold

  • Built new facility to vertically integrate packaging activities in Hudson, NC

    Filed 11 patents and were issued 8